Premium
Clinical Pharmacogenomics: Opportunities and Challenges at Point of Care
Author(s) -
Scott S A
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.196
Subject(s) - pharmacogenomics , clinical pharmacology , turnaround time , medicine , point of care , clinical practice , intensive care medicine , pharmacology , computer science , family medicine , nursing , operating system
One of the major barriers to implementing clinical pharmacogenomics has been the efficient integration of rapid turnaround‐time genetic testing into routine clinical practice. To address this specific challenge, both point‐of‐care and preemptive pharmacogenomic testing programs, initially centered on cardiovascular pharmacogenomics, have recently been deployed. Early results indicate that these strategies are feasible and probably beneficial clinically; however, despite these exciting advances toward implementing clinical pharmacogenomics, challenges to widespread adoption remain. Clinical Pharmacology & Therapeutics (2013); 93 1, 33–35. doi: 10.1038/clpt.2012.196